Cargando…
Clinical efficacy of osimertinib for a patient with ileus due to peritoneal carcinomatosis
We report a patient of stage IV lung adenocarcinoma who developed ileus due to peritoneal carcinomatosis. We placed an ileus tube and started an oral intake of osimertinib. Within one month, the tumor had shrunk, and the ileus was controlled.
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7044355/ https://www.ncbi.nlm.nih.gov/pubmed/32128186 http://dx.doi.org/10.1002/ccr3.2645 |
_version_ | 1783501553225695232 |
---|---|
author | Kawaguchi, Yo Hanaoka, Jun Hayashi, Hideki Fukuda, Yoshihisa Iihara, Hirotoshi Suzuki, Akio Sugiyama, Tadashi |
author_facet | Kawaguchi, Yo Hanaoka, Jun Hayashi, Hideki Fukuda, Yoshihisa Iihara, Hirotoshi Suzuki, Akio Sugiyama, Tadashi |
author_sort | Kawaguchi, Yo |
collection | PubMed |
description | We report a patient of stage IV lung adenocarcinoma who developed ileus due to peritoneal carcinomatosis. We placed an ileus tube and started an oral intake of osimertinib. Within one month, the tumor had shrunk, and the ileus was controlled. |
format | Online Article Text |
id | pubmed-7044355 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-70443552020-03-03 Clinical efficacy of osimertinib for a patient with ileus due to peritoneal carcinomatosis Kawaguchi, Yo Hanaoka, Jun Hayashi, Hideki Fukuda, Yoshihisa Iihara, Hirotoshi Suzuki, Akio Sugiyama, Tadashi Clin Case Rep Case Reports We report a patient of stage IV lung adenocarcinoma who developed ileus due to peritoneal carcinomatosis. We placed an ileus tube and started an oral intake of osimertinib. Within one month, the tumor had shrunk, and the ileus was controlled. John Wiley and Sons Inc. 2020-01-03 /pmc/articles/PMC7044355/ /pubmed/32128186 http://dx.doi.org/10.1002/ccr3.2645 Text en © 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Reports Kawaguchi, Yo Hanaoka, Jun Hayashi, Hideki Fukuda, Yoshihisa Iihara, Hirotoshi Suzuki, Akio Sugiyama, Tadashi Clinical efficacy of osimertinib for a patient with ileus due to peritoneal carcinomatosis |
title | Clinical efficacy of osimertinib for a patient with ileus due to peritoneal carcinomatosis |
title_full | Clinical efficacy of osimertinib for a patient with ileus due to peritoneal carcinomatosis |
title_fullStr | Clinical efficacy of osimertinib for a patient with ileus due to peritoneal carcinomatosis |
title_full_unstemmed | Clinical efficacy of osimertinib for a patient with ileus due to peritoneal carcinomatosis |
title_short | Clinical efficacy of osimertinib for a patient with ileus due to peritoneal carcinomatosis |
title_sort | clinical efficacy of osimertinib for a patient with ileus due to peritoneal carcinomatosis |
topic | Case Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7044355/ https://www.ncbi.nlm.nih.gov/pubmed/32128186 http://dx.doi.org/10.1002/ccr3.2645 |
work_keys_str_mv | AT kawaguchiyo clinicalefficacyofosimertinibforapatientwithileusduetoperitonealcarcinomatosis AT hanaokajun clinicalefficacyofosimertinibforapatientwithileusduetoperitonealcarcinomatosis AT hayashihideki clinicalefficacyofosimertinibforapatientwithileusduetoperitonealcarcinomatosis AT fukudayoshihisa clinicalefficacyofosimertinibforapatientwithileusduetoperitonealcarcinomatosis AT iiharahirotoshi clinicalefficacyofosimertinibforapatientwithileusduetoperitonealcarcinomatosis AT suzukiakio clinicalefficacyofosimertinibforapatientwithileusduetoperitonealcarcinomatosis AT sugiyamatadashi clinicalefficacyofosimertinibforapatientwithileusduetoperitonealcarcinomatosis |